The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.
April 19th 2024
Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases
The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia
1.5 Credits / Neurology, Psychiatry
View More
Managing Bipolar Disorder: The Pharmacist’s Role in Delivering Quality Care
1.0 Credits / Psychiatry
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Actavis Resubmits Cariprazine Approval Application to FDA
January 8th 2015The FDA has acknowledged receipt of Actavis's resubmitted New Drug Application for its investigational atypical antipsychotic, cariprazine, which is indicated for the treatment of patients with schizophrenia and manic or mixed episodes associated with bipolar I disorder.
Read More
Long-Term Bipolar Treatment Maintains Cognitive Health
January 6th 2015Cognitive impairment in patients with bipolar disorder is a growing research priority. Long suspected to be restricted to those with symptomatic illness, cognitive impairment has also been found in patients who are well controlled and euthymic.
Read More
Adherence Issues with Antidepressants in Bipolar Patients
December 25th 2014Bipolar patients are among the most difficult to treat, in part because mania is alluring and in part because they are often poor historians. As with any patient who must take medication for a chronic condition, bipolar patients' adherence rates generally decline over time. About two-thirds of bipolar patients take more than 1 medication for this condition, and an antidepressant is often one component of the drug regimen.
Read More
Bipolar Patients at High Risk for Self-Harm Recurrence
December 5th 2014Up to 60% of patients diagnosed with bipolar disorder cause harm to themselves at least once throughout their lifetimes, and at least 5% of them commit suicide. Nevertheless, few prospective studies have examined self-harm in BPD patients specifically.
Read More
Ethnic Minorities Still Receiving Inferior Mental Health Treatment, Says APA Journal
December 5th 2014Primary care that includes mental health screenings and treatments that take into account a patient's language and cultural background can help address mental health care disparities among ethnic minorities.
Read More
FDA Grants Priority Review to Bipolar Indication for Schizophrenia Drug
November 14th 2014Actavis's supplemental New Drug Application for asenapine to treat manic or mixed episodes related to bipolar disorder in pediatric patients has been accepted by the FDA and given priority review status.
Read More